Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. C
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase. Conventional skeletal formula and stylized representation, showing atoms (except hydrogen) as color coded circles.
Size: 5779px × 10000px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: None
Keywords: bcr-abl, bosutinib, bosutinibe, cancer, carbon, chlorine, chromosome, chronic, cml, hydrogen, inhibitor, kinase, leukemia, myelogenous, nitrogen, oncology, oxygen, philadelphia, src, tumor, tyrosine
